Search All Tech Briefings

Search technology briefings produced by NIHR Innovation Observatory. These are short reports on new or repurposed medicines that we have already sent to our stakeholders. Only those technologies (medicines) that are within the scope of our stakeholders will have a technology briefing available. Search our technology briefings by intervention (drug or device), specific indication (disease or condition), or general therapeutic area.

| 1152 Results

Clear All Filters

Title	Intervention	Indication	Therapeutic Area	Year	Actions
Remimazolam for general anaesthesia – first line	Remimazolam (CNS 7056; ONO-2745)	Anaesthesia	Neurology	2020	View \| Download
Remimazolam for procedural sedation	Remimazolam (CNS 7056; ONO-2745)	Procedural sedation	Neurology	2020	View \| Download
Repotrectinib for treating advanced or metastatic nonsmall-cell lung cancer with ROS1-postive mutation	Repotrectinib (TPX 0005)	Non-small-cell lung cancer (NSCLC)	Lung and Respiratory Cancer	2023	View \| Download
Resmetirom for non-alcoholic steatohepatitis	Resmetirom (MGL-3196)	Non-alcoholic steatohepatitis (NASH)	Hepatology	2023	View \| Download
Retifanlimab for advanced/metastatic merkel cell carcinoma	Retifanlimab (INCMGA00012; MGA-012)	Merkel cell carcinoma (MCC)	Skin Cancer	2021	View \| Download
Retifanlimab for squamous carcinoma of the anal canal – after platinum based chemotherapy	Retifanlimab (INCMGA00012; MGA-012)	Anal cancer	Gastrointestinal Cancer	2020	View \| Download
Retifanlimab with chemotherapy for previously untreated metastatic non-small-cell lung cancer	Endocrine therapy , Ribociclib (Kisqali; LEE-011; ribociclib succinate)	Breast cancer , Non-small-cell lung cancer (NSCLC)	Breast Cancer , Lung and Respiratory Cancer	2024	View \| Download
Rexmyelocel-T for critical limb ischaemia in patients with diabetes mellitus	REX-001 (Rexmyelocel-T)	Critical limb ischaemia (CLI)	Cardiovascular System	2017	View \| Download
Rezafungin for previously untreated invasive candidiasis	Rezafungin (CD101)	Invasive candidasis	Haematology , Infectious Disease	2022	View \| Download
Ribociclib (Kisqali) and fulvestrant for advanced HR positive, HER2‐negative breast cancer in postmenopausal women, first or second line	Fulvestrant (Faslodex) , Ribociclib (Kisqali; LEE-011; ribociclib succinate)	Breast cancer	Breast Cancer	2017	View \| Download